Invention Grant
- Patent Title: Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
-
Application No.: US14226615Application Date: 2014-03-26
-
Publication No.: US09290444B2Publication Date: 2016-03-22
- Inventor: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Steven Fung , Peer B. Jacobson , Lynne E. Rueter , Marina I. Strakhova , Jiahong Wang , Jyoti R. Patel , Qi Shuai , James T. Link , Jeffrey J. Rohde , Jurgen Dinges , Bryan K. Sorensen , Martin Winn , Hong Yong , Vince S. Yeh
- Applicant: ABBVIE INC.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: C07C235/14
- IPC: C07C235/14 ; A61K31/165 ; A61K31/19 ; A61K31/4439 ; C07C235/22 ; C07C237/24 ; C07C271/28 ; C07C311/46 ; C07D207/48 ; C07D257/04 ; C07D261/08 ; C07D295/088 ; C07D401/04
Abstract:
The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.
Public/Granted literature
- US20150065508A1 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME Public/Granted day:2015-03-05
Information query
